Guangzhou Innogen Pharmaceutical Group Co., Ltd (SEHK: 2591)
Health Care · Biotechnology · CN
HK$3.60
-3.49% today · -89.9% 1Y
Guangzhou Innogen Pharmaceutical Group Co., Ltd (SEHK: 2591) operates in the Biotechnology industry within the Health Care sector. The company is valued at $209.56M and employs 214 people.
Over the last twelve months the share price has lost 89.9%, trading between 3.44 and 48.36.
Tweenvest scores Guangzhou Innogen Pharmaceutical Group Co., Ltd across four factors: quality 50/100, value 55/100. Its strongest factor is value.
2591 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $209.56M
- Revenue (TTM)
- $22.57M
- P/E
- —
- EPS
- -0.74
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- HK$48.36
- 52-week low
- HK$3.44
- Avg volume (3M)
- —
- Shares outstanding
- 456.82M
- Employees
- 214
- Next earnings
- —
About Guangzhou Innogen Pharmaceutical Group Co., Ltd
Guangzhou Innogen Pharmaceutical Group Co Ltd operates as a China-based investment holding firm with a core mission to research, develop, and bring to market medicinal products. The company specializes in producing innovative, human-compatible, and extended-duration GLP-1 receptor agonists, specifically targeting the treatment of diabetes and other metabolic conditions.
- ISIN
- CNE1000071Q7
- Founded
- 2014
- Listed since
- Aug 15, 2025
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cartesian Therapeutics, Inc.NasdaqGM: RNAC | $213.45M | $7.06 | -4.14% |
| Lyell Immunopharma, Inc.NasdaqGS: LYEL | $213.44M | $8.71 | -5.94% |
| Genome & CompanyKOSDAQ: A314130 | $212.80M | ₩5,470.00 | -0.55% |
| Invivyd, Inc.NasdaqGM: IVVD | $212.58M | $0.74 | +2.61% |
| HLB Therapeutics Co.,Ltd.KOSDAQ: A115450 | $208.16M | ₩3,175.00 | +28.54% |
| TaiGen Biopharmaceuticals Holdings LimitedTPEX: 4157 | $207.71M | NT$9.33 | +7.86% |
| Genomictree Inc.KOSDAQ: A228760 | $206.67M | ₩11,320.00 | -7.21% |
| Shanghai Rightongene Biotechnology Co., Ltd.SHSE: 688217 | $204.58M | CN¥24.83 | -3.20% |
Figures last refreshed Oct 11, 2026.